Jennifer AltomonteCEO at Fusix BiotechSpeaker
Profile
Jennifer Altomonte is the CEO and a co-founder of Fusix Biotech, which was founded in 2022 as a university spin-out from the Technical University of Munich (TUM) in Germany. She is a molecular biologist and virologist with over 20 years of experience in viral engineering and in the development of oncolytic viral cancer immunotherapeutics. She is the inventor of the InFUSE platform that is being developed by Fusix.
Agenda Sessions
Startup spotlight pitch competition
, 15:30View Session